Retatrutide
30mg
High-concentration retatrutide (30mg) lyophilized vial. Same triple GIP/GLP-1/glucagon receptor agonist compound as the 15mg formulation, provided at double concentration for research protocols requiring higher doses or larger animal models. Refer to the retatrutide 15mg product listing for complete pharmacological profile and citations.
Pricing
Mechanism of Action
Identical mechanism to retatrutide 15mg — triple GIP/GLP-1/glucagon receptor agonism. See retatrutide 15mg listing for full details.
Properties
Molecular Weight
5260 Da (approx.)
Half-Life
~6 days
Storage
Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 30 days.
Research Applications
References & Citations
(1)Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Jastreboff AM, Kaplan LM, Frías JP, et al.
Related Products
Research Use Only
This product is intended strictly for in-vitro research, educational, and laboratory use. Not for human consumption. The information provided is based on published research and does not constitute medical advice.